Contagion® Announces 2019 Section Editors
CRANBURY, N.J.--(BUSINESS WIRE)--Jan 15, 2019--Contagion®, the nation’s leading digital and print resource dedicated to providing up-to-date, disease-specific information to health care practitioners and specialists in the field of infectious diseases, announces the appointment of its 2019 section editors for the print publication. These medical professionals will work alongside the editorial staff of Contagion ® to deliver timely information about recent medical developments and research to the evolving infectious disease community.
“We look forward to working with some of the most respected medical professionals in the infectious disease community,” said Michael J. Hennessy Jr., president of MJH Associates Inc., parent company of Contagion ®. “Their impeccable experience and contributions in the field will continue to grow and deliver unprecedented information to our readers.”
Spearheading the team is Jason Gallagher, Pharm.D., FCCP, FIDSA, BCPS, who will continue on for a second year as editor in chief.
“I am excited to be at the helm of Contagion® for another year and to kick off 2019 with an A-list team of expert content editors who will bring their experience and insight in their respective fields to our audience of professional health care providers,” Dr. Gallagher said.
Introducing the Contagion® section editors:Jason Gallagher, Pharm.D., FCCP, FIDSA, BCPS; Editor in Chief Gallagher currently serves as a clinical professor at Temple University School of Pharmacy and is a clinical pharmacy specialist in infectious diseases at Temple University Hospital. He is also the director of the PGY2 Residency in Infectious Diseases Pharmacy Program at Temple. Monica V. Mahoney, Pharm.D., BCPS-AQ ID, BCIDP; In the Literature Mahoney serves as the clinical pharmacy coordinator of infectious diseases at Beth Israel Deaconess Medical Center. She is also a board-certified pharmacotherapy specialist and actively involved in the Society of Infectious Diseases Pharmacists (SIDP), American Society of Health-System Pharmacists (ASHP), American College of Clinical Pharmacy (ACCP), and the Massachusetts Society of Health-System Pharmacists (MSHP). Jason J. Schafer, Pharm.D., M.P.H., BCPS-AQ ID, BCIDP, AAHIVP; HIV Schafer is an associate professor of pharmacy practice at the Jefferson College of Pharmacy and a clinical pharmacy specialist in HIV Ambulatory Care at the Thomas Jefferson University in Philadelphia, Pennsylvania. He is board-certified in pharmacotherapy and infectious diseases (BCPS and BCIDP) and certified by the American Academy of HIV Medicine (AAHIVM) as a practicing HIV pharmacist (AAHIVP). Wendy M. Bamberg, M.D., Emerging/Re-Emerging Infections Bamberg serves as a medical epidemiologist and Health Care-Associated Infections and Antimicrobial Resistance program manager at the Colorado Department of Public Health and Environment. She is also board certified in internal medicine and infectious diseases. Ryan K. Shields, Pharm.D., M.S.; Multidrug-Resistant Infections Shields serves as an associate professor in the department of medicine at the University of Pittsburgh in Pennsylvania. He is a clinical pharmacist in infectious diseases at the University of Pittsburgh Medical Center and directs a research laboratory to study antimicrobial resistance. Conan MacDougall, Pharm.D., M.A.S., BCPS, BCIDP; Stewardship & Prevention MacDougall serves as a professor of clinical pharmacy in the department of clinical pharmacy at the University of California, San Francisco. He also provides clinical service to the Infectious Diseases Consult Service and Antimicrobial Stewardship Program at UCSF Medical Center. Sara K. Schultz, M.D., Case Studies Schultz is an assistant professor of medicine in the division of Infectious Diseases and HIV Medicine at Drexel College of Medicine in Philadelphia, Pennsylvania. She also serves as Associate Program Director for the ID Fellowship at Drexel. Her research interests are in sexually transmitted disease prevention and clinical skills education. She is board certified in internal medicine and infectious disease.
Contagion® is a fully integrated print and digital news publication that provides health care practitioners and aligned professionals with timely information and resources to improve patient outcomes and positively affect the identification, diagnosis, treatment and prevention of infectious disease. It also incorporates the Outbreak Monitor, which provides real-time information about infectious disease outbreaks by geographical region. Contagion® is part of MJH Associates, Inc., a full-service health care communications company offering education, research and medical media.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190115005805/en/
CONTACT: Contagion Media:
Alexandra Ventura, 609-716-7777, ext. 121
firstname.lastname@example.orgJohn Patricolo, 609-325-4630
KEYWORD: UNITED STATES NORTH AMERICA NEW JERSEY
INDUSTRY KEYWORD: HEALTH HOSPITALS INFECTIOUS DISEASES COMMUNICATIONS PUBLISHING
Copyright Business Wire 2019.
PUB: 01/15/2019 01:22 PM/DISC: 01/15/2019 01:22 PM